Empowered Funds LLC Reduces Stock Holdings in Avanos Medical, Inc. (NYSE:AVNS)

Empowered Funds LLC trimmed its position in Avanos Medical, Inc. (NYSE:AVNS) by 66.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 63,743 shares of the company’s stock after selling 127,491 shares during the quarter. Empowered Funds LLC’s holdings in Avanos Medical were worth $1,532,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Paradice Investment Management LLC increased its holdings in shares of Avanos Medical by 5.4% in the 2nd quarter. Paradice Investment Management LLC now owns 1,344,949 shares of the company’s stock worth $26,791,000 after buying an additional 69,389 shares during the last quarter. Cornercap Investment Counsel Inc. acquired a new stake in shares of Avanos Medical during the second quarter worth $1,077,000. Boston Partners purchased a new stake in Avanos Medical in the first quarter valued at approximately $571,000. Deerfield Management Company L.P. Series C acquired a new stake in Avanos Medical during the 2nd quarter worth about $551,000. Finally, AQR Capital Management LLC increased its holdings in shares of Avanos Medical by 21.0% during the 2nd quarter. AQR Capital Management LLC now owns 146,983 shares of the company’s stock valued at $2,875,000 after purchasing an additional 25,467 shares in the last quarter. 95.17% of the stock is owned by institutional investors.

Avanos Medical Price Performance

NYSE:AVNS opened at $18.02 on Friday. The stock’s fifty day moving average is $21.95 and its two-hundred day moving average is $21.56. The company has a market capitalization of $828.20 million, a P/E ratio of 54.00 and a beta of 0.92. Avanos Medical, Inc. has a 52 week low of $17.39 and a 52 week high of $25.36. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.